<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15557">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02904356</url>
  </required_header>
  <id_info>
    <org_study_id>AAAQ8771</org_study_id>
    <nct_id>NCT02904356</nct_id>
  </id_info>
  <brief_title>Repetitive Transcranial Magnetic Stimulation (rTMS) for Obsessive-Compulsive Disorder (OCD)</brief_title>
  <official_title>Repetitive Transcranial Magnetic Stimulation (rTMS) for Obsessive-Compulsive Disorder (OCD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sameer Sheth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to assess the impact of repetitive transcranial magnetic stimulation (rTMS)
      on brain imaging and neurophysiological measures of cognitive control in patients with
      Obsessive-Compulsive Disorder (OCD).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in fMRI BOLD response</measure>
    <time_frame>Up to 1 month</time_frame>
    <description>Changes in blood-oxygen-level dependent (BOLD) correlates corresponding to task engagement before and after rTMS will be assessed.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>repetitive Transcranial Magnetic Stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Brainsway H-coil for repetitive transcranial magnetic stimulation</intervention_name>
    <description>High-frequency rTMS will be administered to the medial prefrontal cortex for 3 weeks. The intensity of stimulation will be based on resting-motor threshold (RMT).</description>
    <arm_group_label>rTMS</arm_group_label>
    <other_name>rTMS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary diagnosis of Obsessive Compulsive Disorder, as confirmed by the Structured
             Clinical Interview for the DSM-IV-TR (SCID).

          -  Subjects should have at least a moderate level of OCD severity as defined by a
             Yale-Brown Obsessive Compulsive Disorder Scale (YBOCS) score of â‰¥ 20.

        Exclusion Criteria:

          -  Individuals diagnosed by the investigators with the following conditions: Bipolar
             Disorder (lifetime), any Psychotic Disorder (lifetime), history of substance abuse or
             dependence within the past year (expect nicotine and caffeine).

          -  An Axis II Personality Disorder, which in the judgment of the investigator may hinder
             the patient in completing the procedures required by the study protocol.

          -  Individuals with a clinically defined neurological disorder including, but not
             limited to: stroke, tics, space occupying brain lesion, any history of seizures
             except those therapeutically induced by electroconvulsive therapy (ECT), history of
             cerebrovascular accident, transient ischemic attack within two years, cerebral
             aneurysm, dementia, Parkinson's Disease, Huntington Chorea, Multiple Sclerosis.

          -  Increased risk of seizure for any reason, including prior diagnosis of increased
             intracranial pressure (such as after large infarctions or trauma), or history of
             significant head trauma with loss of consciousness for &gt;5 minutes.

          -  History of treatment with rTMS therapy for any disorder.

          -  History of treatment with Deep Brain Stimulation.

          -  Cardiac pacemakers, implanted medication pumps, intracardiac lines, or acute,
             unstable cardiac disease.

          -  Intracranial implants (e.g. aneurysm clips, shunts, stimulators, cochlear implants,
             or electrodes) or any other metal object within or near the head, excluding the
             mouth, that cannot be safely removed.

          -  Current illicit drug use.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sameer Sheth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yagna Pathak, PhD</last_name>
    <email>yp2385@cumc.columbia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yagna Pathak, PhD</last_name>
      <email>yp2385@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sameer Sheth, MD,PhD</last_name>
      <phone>212-317-4638</phone>
      <email>ss4451@cumc.columbia.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 5, 2017</lastchanged_date>
  <firstreceived_date>August 25, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Sameer Sheth</investigator_full_name>
    <investigator_title>Assistant Professor of Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>OCD</keyword>
  <keyword>TMS</keyword>
  <keyword>Neuromodulation</keyword>
  <keyword>Obsessive-Compulsive Disorder</keyword>
  <keyword>Transcranial Magnetic Stimulation</keyword>
  <keyword>Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
    <mesh_term>Compulsive Behavior</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
